Discover how much money can be saved in your clinical trial!

Preventing Duplicate Research Subjects Across Sponsors: How Verified Clinical Trials Protects Clinical Research Integrity

Introduction In today’s fast-paced clinical research environment, ensuring data integrity and participant safety has never been more critical. One of the most persistent threats to these core objectives is the issue of duplicate research subjects in clinical trials—individuals who enroll in multiple studies concurrently or in close succession, often without disclosing prior participation. Verified Clinical …

Read more

Complexities of Duplicate Subjects in GLP-1 and Obesity Clinical Trials

Clinical trials for GLP-1 receptor agonists and obesity clinical trials face unique challenges due to the high level of interest from participants who are eager to lose weight or manage metabolic disorders. One major concern is duplicate enrollment in clinical trials, where subjects attempt to participate in multiple studies simultaneously. This can happen for several …

Read more

Protecting Clinical Trials From Duplicate Research Subjects with Verified Clinical Trials: Ensuring Data Integrity and Participant Safety

Clinical trials are the backbone of medical advancements, providing the data necessary to develop new treatments and therapies. However, one of the biggest challenges facing the research community is ensuring data integrity and participant safety. Duplicate subjects in clinical trials, fraudulent participation, and non-compliance can compromise results and endanger both subjects and the broader public. …

Read more

Detect and Prevent Duplicate Subjects in Clinical Trials: A Global Challenge

The integrity of clinical trials is paramount to ensuring reliable results, patient safety, and regulatory compliance. However, duplicate subjects in clinical trials—individuals who enroll in multiple studies simultaneously or in rapid succession—pose a significant risk to data accuracy and patient safety. The issue is not confined to specific regions such as Florida or California or …

Read more

Practices to Detect and Prevent Cross Sponsor Duplicate Subjects in Clinical Trials

The integrity of clinical trials hinges on ensuring that each participant is unique to the study and does not enroll multiple times in the same trial or across different studies. Duplicate research subjects introduce significant risks, compromising data validity, regulatory compliance, and overall study success. While detection efforts at the study’s conclusion can identify such …

Read more

ProofPilot and Verified Clinical Trials Announce Strategic Partnership to Scale Participant Integrity in Clinical Trial Recruitment

NEW YORK, March 19, 2024 /PRNewswire/ — ProofPilot, the industry’s only platform for clinical trial automation, guidance and flawless execution, is excited to announce its strategic partnership with Verified Clinical Trials (VCT), the world’s leading validated research participant registry and verification platform. This collaboration marks a significant milestone in improving data integrity by reducing the risk of ineligible patients. VCT …

Read more

Mitigating the Effects of Nonadherence in Clinical Trials by Preventing Duplicate Subjects in Clinical Trials

Nonadherence in clinical trials remains a significant hurdle, leading to compromised data integrity, skewed results, and costly delays. One often overlooked but critical factor contributing to nonadherence is the presence of duplicate subjects and professional research subjects—individuals who enroll in multiple trials simultaneously or misrepresent their participation history. The Hidden Impact of Duplicate Subjects Nonadherence …

Read more

Professional Patients in Clinical Trials - Verified Clinical Trials

 The Growing Obesity Epidemic, Clinical Trials, and the Rising Challenge of Duplicate Subjects

The global obesity epidemic continues to surge, leading to an unprecedented demand for effective treatments and numerous clinical trials. As a result, the clinical trial landscape is rapidly expanding, with numerous companies conducting a wide array of obesity-related studies. Among these, GLP-1 receptor agonists have emerged as a leading therapeutic option, prompting a significant increase …

Read more

duplicate subjects in clinical trials

How to Avoid The Dangers of Duplicate Participants in Clinical Trials

The prevalence of duplicate participants in clinical trials poses significant risks, compromising the integrity of data and the safety of the patients involved. To delve into this matter, we spoke with Kerri Weingard, a seasoned veteran in the field and the co-founder of Verified Clinical Trials (VCT), who brings a wealth of knowledge and experience. In this …

Read more

 Velocity Clinical Research Partners with Verified Clinical Trials to combat duplicate enrollment problem in clinical trials

January 30, 2025 07:07 ET | Source: Velocity Clinical Research, Inc.Follow DURHAM, N.C., Jan. 30, 2025 (GLOBE NEWSWIRE) — Velocity Clinical Research, the leading multi-specialty clinical research organization, has partnered with Verified Clinical Trials (VCT) to set a new benchmark for patient safety and data quality in clinical trials through a new technological implementation at Velocity’s 80+ …

Read more